Jasdeep S. Nanra

408 total citations
7 papers, 326 citations indexed

About

Jasdeep S. Nanra is a scholar working on Infectious Diseases, Molecular Biology and Ophthalmology. According to data from OpenAlex, Jasdeep S. Nanra has authored 7 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 3 papers in Molecular Biology and 2 papers in Ophthalmology. Recurrent topics in Jasdeep S. Nanra's work include Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial biofilms and quorum sensing (3 papers) and Ocular Infections and Treatments (2 papers). Jasdeep S. Nanra is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial biofilms and quorum sensing (3 papers) and Ocular Infections and Treatments (2 papers). Jasdeep S. Nanra collaborates with scholars based in United States, Belgium and Algeria. Jasdeep S. Nanra's co-authors include Annaliesa S. Anderson, Ingrid L. Scully, Kathrin U. Jansen, David Cooper, Robert G. K. Donald, Pamela S. Fink, Alita A. Miller, Sandra Buitrago, Yekaterina Timofeyeva and Lisa K. McNeil and has published in prestigious journals such as Infection and Immunity, Vaccine and Human Vaccines & Immunotherapeutics.

In The Last Decade

Jasdeep S. Nanra

6 papers receiving 317 citations

Peers

Jasdeep S. Nanra

ID

MB

MICRO

EPIDE

PHEOH

Hirschhausen Nina Germany

Grace R. Pidwill United Kingdom

Yekaterina Timofeyeva United States

Andreas Uekötter Germany

Jessica L. Hastie United States

Vien T. M. Le United States

Frances E. Rivera United States

Caná L. Ross United States

Kathrin Stelzner Germany

Yuru Shi China

Hirschhausen Nina Germany

Jasdeep S. Nanra

258 ×1.1

ID

295 ×1.6

MB

58 ×0.9

MICRO

23 ×0.5

EPIDE

38 ×0.9

PHEOH

Citations per year, relative to Jasdeep S. Nanra Jasdeep S. Nanra (= 1×) peers Hirschhausen Nina

Countries citing papers authored by Jasdeep S. Nanra

Since Specialization

Citations

This map shows the geographic impact of Jasdeep S. Nanra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasdeep S. Nanra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasdeep S. Nanra more than expected).

Fields of papers citing papers by Jasdeep S. Nanra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasdeep S. Nanra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasdeep S. Nanra. The network helps show where Jasdeep S. Nanra may publish in the future.

Co-authorship network of co-authors of Jasdeep S. Nanra

This figure shows the co-authorship network connecting the top 25 collaborators of Jasdeep S. Nanra. A scholar is included among the top collaborators of Jasdeep S. Nanra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasdeep S. Nanra. Jasdeep S. Nanra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Borys, Dorota, Ronald Smulders, Miwa Haranaka, et al.. (2024). Safety, reactogenicity, and immunogenicity of a novel 24-valent pneumococcal vaccine candidate in healthy, pneumococcal vaccine-naïve Japanese adults: A phase 1 randomized dose-escalation trial. Vaccine. 44. 126545–126545.

2.

Frenck, Robert W., C. Buddy Creech, Eric Sheldon, et al.. (2016). Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study. Vaccine. 35(2). 375–384. 51 indexed citations

3.

Scully, Ingrid L., Yekaterina Timofeyeva, David Keeney, et al.. (2015). Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection. Vaccine. 33(41). 5452–5457. 31 indexed citations

4.

Nanra, Jasdeep S., Sandra Buitrago, Jennifer Ng, et al.. (2013). Capsular polysaccharides are an important immune evasion mechanism forStaphylococcus aureus. Human Vaccines & Immunotherapeutics. 9(3). 480–487. 97 indexed citations

5.

Anderson, Annaliesa S., Alita A. Miller, Robert G. K. Donald, et al.. (2012). Development of a multicomponentStaphylococcus aureusvaccine designed to counter multiple bacterial virulence factors. Human Vaccines & Immunotherapeutics. 8(11). 1585–1594. 81 indexed citations

6.

Nanra, Jasdeep S., Yekaterina Timofeyeva, Sandra Buitrago, et al.. (2009). Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: Implications for vaccine design. Vaccine. 27(25-26). 3276–3280. 36 indexed citations

7.

Sellman, Bret R., et al.. (2008). Expression of Staphylococcus epidermidis SdrG Increases following Exposure to an In Vivo Environment. Infection and Immunity. 76(7). 2950–2957. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact